#美国探讨比特币战略储备 The wave of brain-computer interface financing is coming. Can technological breakthroughs trigger the next wave of investment opportunities?

From laboratory research to clinical applications, the brain-computer interface track is experiencing explosive growth. Neuralink announced that it will launch large-scale commercialization plans in 2026, including fully automated surgical procedures, which means the technology is moving from proof of concept to real-world application.

In terms of technological progress, Neuralink has completed the world's first human implantation surgery. This year's product development plans show that the chip has been miniaturized to the size of a coin, with electrodes as thin as a strand of hair. The three-product matrix covers application scenarios such as thought-controlled computers and visual restoration. An even more ambitious goal is to surpass 25,000 electrodes by 2028, directly interfacing with AI systems.

The domestic track is also booming. In clinical cases in Shanghai, patients can now play games and chess through brain-computer interfaces; the number of "Beiniao No. 1" implant cases has reached 6; research institutions such as Tsinghua University and Sun Yat-sen Hospital are entering clinical trial phases. Data shows that from January to November 2025, financing in the brain-computer field reached 24 rounds, a 30% year-on-year increase, with leading capital firms like Sequoia and Hillhouse making large investments. Neuralink's latest funding round has valued the company at $9 billion, setting a record.

$ETH, $BTC, $BNB, and other cryptocurrencies are often highly correlated with the technology innovation cycle. Industry experts admit that true brain-machine integration still requires 5-10 years, but capital has already begun to position early. Will this technological shift from experimentation to application become the next market hotspot? Stay tuned.